Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

PMID: 36944799
Journal: NATURE MEDICINE
Year: 2023
Reference: Nat Med. 2023 Dec;29(12):3271. doi: 10.1038/s41591-023-02312-9.
Impact factor:
Publication type: Letter or abstract
Authors: Banchereau, Romain; Castellano, Daniel; Crabb, Simon J; Daelemans, Sofie; Duran, Ignacio; Gravis, Gwenaelle; Herranz, Urbano Anido; Kockx, Mark; Linch, Mark; Maillet, Denis et al.
DOI: 10.1038/s41591-023-02312-9

PUF60-related developmental disorder: A case series and phenotypic analysis of 10 additional patients with monoallelic PUF60 variants.

PMID: 37303278
Journal: AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Year: 2023
Reference: Am J Med Genet A. 2023 Jun 11. doi: 10.1002/ajmg.a.63313.
Impact factor:
Publication type: Letter or abstract
Authors: Ansari, M; Ashraf, T; Calder, A; Cueto-Gonzalez, Anna M feminine; Day, M; Fernandez Alvarez, P; Foster, A; Grimes, H; Lahiri, N; Low, Karen J et al.
DOI: 10.1002/ajmg.a.63313

Pulsed radiofrequency in a paediatric patient with disabling ACNES.

PMID: 36940851
Journal: Revista espanola de anestesiologia y reanimacion
Year: 2023
Reference: Rev Esp Anestesiol Reanim (Engl Ed). 2023 Aug-Sep;70(7):395-398. doi: 10.1016/j.redare.2022.10.008. Epub 2023 Mar 20.
Impact factor:
Publication type: Letter or abstract
Authors: Medel, J; Mesas, A; Sanchez, V; Sanchez, V; Server, A et al.
DOI: 10.1016/j.redare.2022.10.008

Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies.

PMID: 37425344
Journal: Therapeutics and Clinical Risk Management
Year: 2023
Reference: Ther Clin Risk Manag. 2023 Jul 4;19:567-578. doi: 10.2147/TCRM.S410574. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Castells-Sala, Cristina; Farinas, Oscar; Lopez-Chicon, Patricia; Perez, Maria Luisa; Piteira, Ana Rita; Tabera, Jaime; Vilarrodona, Anna et al.
DOI: 10.2147/TCRM.S410574

Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.

PMID: 37682330
Journal: PEDIATRIC RADIOLOGY
Year: 2023
Reference: Pediatr Radiol. 2023 Sep 8. doi: 10.1007/s00247-023-05745-z.
Impact factor:
Publication type: Paper in international publication
Authors: Adams, Madeleine; Bertolini, Patrizia; Bisogno, Gianni; Bouhamama, Amine; Caro-Dominguez, Pablo; Charon, Valerie; Chatziantoniou, Cyrano; Coma, Ana; Coma, Ana; Dandis, Rana et al.
DOI: 10.1007/s00247-023-05745-z

Question: Shock with electrocardiogram deterioration.

PMID: 38149524
Journal: European Heart Journal-Acute Cardiovascular Care
Year: 2023
Reference: Eur Heart J Acute Cardiovasc Care. 2023 Dec 27:zuad120. doi: 10.1093/ehjacc/zuad120.
Impact factor:
Publication type: Paper in international publication
Authors: Barrabes, Jose A; Calvo-Barcelo, Maria; Vidal-Burdeus, Maria et al.
DOI: 10.1093/ehjacc/zuad120

RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer.

PMID: 37468678
Journal: ONCOGENE
Year: 2023
Reference: Oncogene. 2023 Jul 19. doi: 10.1038/s41388-023-02778-4.
Impact factor:
Publication type: Paper in international publication
Authors: Abad, Maria; Alemany-Chavarria, Merce; Bellio, Chiara; Canals, Francesc; Fasani, Roberta; Greco, Emanuela; Mayans, Carla; Mendez, Olga; Mitjans, Francesc; Nonell, Lara et al.
DOI: 10.1038/s41388-023-02778-4

Randomized Open-Label Controlled Study of Cancer Vaccine OSE2101 Versus Chemotherapy in HLA-A2-positive Patients with Advanced Non-Small Cell Lung Cancer with Resistance to Immunotherapy: ATALANTE-1.

PMID: 37704166
Journal: ANNALS OF ONCOLOGY
Year: 2023
Reference: Ann Oncol. 2023 Aug 1:S0923-7534(23)00790-1. doi: 10.1016/j.annonc.2023.07.006.
Impact factor:
Publication type: Paper in international publication
Authors: Baldini, E; Baldini, E; Besse, B; Besse, B; Bonanno, L; Bonetti, A; Bonnet, C; Cadranel, J; Campelo, M R Garcia; Campelo, R Garcia et al.
DOI: 10.1016/j.annonc.2023.07.006

[Rapidly progressive intracranial large artery aterosclerosis, a rare stroke etiology].

PMID: 37046396
Journal: REVISTA DE NEUROLOGIA
Year: 2023
Reference: Rev Neurol. 2023 Apr 16;76(8):273-275. doi: 10.33588/rn.7608.2022328.
Impact factor:
Publication type: Letter or abstract
Authors: Anton-Jimenez, A; Martinez-Saez, E; Rovira, A; Sarria-Estrada, S; Tortajada-Bustelo, J C et al.
DOI: 10.33588/rn.7608.2022328

Rare Genomic Copy Number Variants Implicate New Candidate Genes for Bicuspid Aortic Valve.

PMID: 37961530
Journal:
Year: 2023
Reference: medRxiv. 2023 Oct 24:2023.10.23.23297397. doi: 10.1101/2023.10.23.23297397. Preprint.
Impact factor:
Publication type: Other (letters to the editor, abstracts, corrigendum, etc.)
Authors: Albasha, Hasan; Alexandri, Nektaria; Andreassi, Maria Grazia; Bianco, Lisa; Bissell, Malenka M; Body, Simon C; Brieva, Luis; Brochet, Bruno; Caffarelli, Anthony; Carlisle, Steven G et al.
DOI: 10.1101/2023.10.23.23297397

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

PMID: 37020259
Journal: Genome Medicine
Year: 2023
Reference: Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8.
Impact factor:
Publication type: Paper in international publication
Authors: Abad, Jorge; Abad, Sebastien; Abassi, Radhiya; Abdelhadi, Nour Mekki; Abdellaoui, Abdelrafie; Abdelmalek, Abdelkrim; Abdoul, Hendy; Abel, Laurent; Abel, Laurent; Abel, Laurent et al.
DOI: 10.1186/s13073-023-01173-8

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).

PMID: 37995519
Journal: Cancer treatment and research communications
Year: 2023
Reference: Cancer Treat Res Commun. 2023 Nov 1;37:100772. doi: 10.1016/j.ctarc.2023.100772.
Impact factor:
Publication type: Paper in international publication
Authors: Ales Martinez, Jose Enrique; Alijotas-Reig, Jaume; Antolin Novoa, Silvia; Anunciacion-Llunell, Ariadna; de la Morena Barrio, Pilar; Echavarria Diaz-Guardamino, Isabel; Escriva-de-Romani, Santiago; Esteve-Valverde, Enrique; Garate, Zita; Gonzalez-Cortijo, Lucia et al.
DOI: 10.1016/j.ctarc.2023.100772

Real-time ultrasound demonstration of uterine isthmus contractions during pregnancy.

PMID: 37481152
Journal: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Year: 2023
Reference: Am J Obstet Gynecol. 2023 Jul 20:S0002-9378(23)00476-3. doi: 10.1016/j.ajog.2023.07.025.
Impact factor:
Publication type: Paper in international publication
Authors: Brik, Maia; Calero, Ines; Carreras, Elena; Casellas, Alba; Catalan, Sara; Farras, Alba; Goya, Maria; Higueras, Teresa; Maiz, Nerea et al.
DOI: 10.1016/j.ajog.2023.07.025

Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.

PMID: 37987641
Journal: CEPHALALGIA
Year: 2023
Reference: Cephalalgia. 2023 Nov;43(11):3331024231214987. doi: 10.1177/03331024231214987.
Impact factor:
Publication type: Paper in international publication
Authors: Ahn, Andrew H; Akerlund, Cecilia; Akerlund, Cecilia A I; Amin, Faisal Mohammad; Amrein, Krisztina; Andelic, Nada; Andreassen, Lasse; Anke, Audny; Antoni, Anna; Ao, Braden Te et al.
DOI: 10.1177/03331024231214987

Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study.

PMID: 37257423
Journal: DERMATOLOGY
Year: 2023
Reference: Dermatology. 2023;239(5):685-693. doi: 10.1159/000530813. Epub 2023 May 31.
Impact factor:
Publication type: Paper in international publication
Authors: Aguayo-Ortiz, Rafael; Ariceta, Gema; Bassas-Freixas, Patricia; Bernia-Petit, Eduardo; Bonfill-Orti, Montserrat; Canueto, Javier; Comas, Jordi; Cruz, Alejandro; Deza, Gustavo; Florez-Menendez, Angeles et al.
DOI: 10.1159/000530813

Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.

PMID: 38145114
Journal:
Year: 2023
Reference: J Health Econ Outcomes Res. 2023 Dec 20;10(2):141-149. doi: 10.36469/001c.85088. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Anton, Jordi; Bittermann, Violetta; Bou, Rosa; Calvo Penades, Immaculada; Calzada Hernandez, Joan; Carriqui Arenas, Sonia; de Lossada, Alfonso; Estepa Guillen, Carolina; Gonzalez Fernandez, Maria I; Iglesias, Estibaliz et al.
DOI: 10.36469/001c.85088

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.

PMID: 37874957
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Oct 24:JCO2301097. doi: 10.1200/JCO.23.01097.
Impact factor:
Publication type: Paper in international publication
Authors: Amat, Paula; Bailen, Rebeca; Barba, Pere; Bardet, Stephane; Bastos, Mariana; Benzaquen, Ana; Blumenberg, Viktoria; Brose, Marcia S; Capdevila, Jaume; Carpio, Cecilia et al.
DOI: 10.1200/JCO.23.01097

Reciprocal regulation between the molecular clock and kidney injury.

PMID: 37487638
Journal: Life Science Alliance
Year: 2023
Reference: Life Sci Alliance. 2023 Jul 24;6(10):e202201886. doi: 10.26508/lsa.202201886. Print 2023 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Barbas, Coral; Chaix, Amandine; Herrero, J Ignacio; Lamas, Santiago; Lin, Terry; Meseguer, Anna; Miguel, Veronica; Panda, Satchidananda; Ramos, Ricardo; Rey-Serra, Carlos et al.
DOI: 10.26508/lsa.202201886

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin.

PMID: 37559832
Journal: International Journal of Chronic Obstructive Pulmonary Disease
Year: 2023
Reference: Int J Chron Obstruct Pulmon Dis. 2023 Aug 4;18:1691-1700. doi: 10.2147/COPD.S410611. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Amaro Rodriguez, Rosanel; Barrecheguren, Miriam; Barrio Guirado, Maria Angeles; Calle Rubio, Myriam; Callejas-Gonzalez, Francisco Javier; Casas-Maldonado, Francisco; Diab-Caceres, Layla; Garcia-Meseguer, Pilar; Hernandez-Perez, Jose Maria; Lazaro-Asegurado, Lourdes et al.
DOI: 10.2147/COPD.S410611

Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates.

PMID: 37762274
Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Year: 2023
Reference: Int J Mol Sci. 2023 Sep 12;24(18):13971. doi: 10.3390/ijms241813971.
Impact factor:
Publication type: Paper in international publication
Authors: Bastus, Neus G; Casonato Melo, Cristiane; Duschl, Albert; Fauerbach, Jonathan A; Fux, Alexandra C; Gessner, Isabel; Himly, Martin; Puntes, Victor; Puntes, Victor; Schlahsa, Laura et al.
DOI: 10.3390/ijms241813971

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.

PMID: 37024284
Journal: GENES & DEVELOPMENT
Year: 2023
Reference: Genes Dev. 2023 Apr 1;37(7-8):303-320. doi: 10.1101/gad.350078.122. Epub 2023 Apr 6.
Impact factor:
Publication type: Paper in international publication
Authors: Beaulieu, Marie-Eve; Casacuberta-Serra, Silvia; Foradada, Laia; Giuntini, Fabio; Gonzalez-Larreategui, Inigo; Grueso, Judit; Jauset, Toni; Kaur, Jastrinjan; Martin-Fernandez, Genesis; Martinez-Martin, Sandra et al.
DOI: 10.1101/gad.350078.122

Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.

PMID: 36977286
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Mar 28:JCO2202363. doi: 10.1200/JCO.22.02363.
Impact factor:
Publication type: Paper in international publication
Authors: Bonnefoi, Herve; Buyse, Marc; Cameron, David; Conte, Pierfranco; Cortazar, Patricia; Cortes, Javier; de Azambuja, Evandro; Denkert, Carsten; Gelber, Richard; Geyer, Charles E Jr et al.
DOI: 10.1200/JCO.22.02363

Reference ranges of thyroid hormones during the first trimester in Catalan women using the Atellica(R) IM Solution Immunoassay Analyzer.

PMID: 37996255
Journal: ANNALS OF CLINICAL BIOCHEMISTRY
Year: 2023
Reference: Ann Clin Biochem. 2023 Nov 23:45632231219387. doi: 10.1177/00045632231219387.
Impact factor:
Publication type: Paper in international publication
Authors: Andrade, Monica Viegas; Blanco, Albert; Bracarense, Henrique; Braga, Paulo Estevao Franco; Comas, Immaculada; Conesa, Laura; de Miranda, Maria Carolina Correa; de Souza, Aline; Diaz-Troyano, Noelia; Ferrer, Roser et al.
DOI: 10.1177/00045632231219387

Reference values for interleukin-6 in the amniotic fluid of asymptomatic pregnant women.

PMID: 36906815
Journal: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
Year: 2023
Reference: Acta Obstet Gynecol Scand. 2023 Apr;102(4):480-485. doi: 10.1111/aogs.14524.
Impact factor:
Publication type: Paper in international publication
Authors: Arevalo, Silvia; Aviles, Maria Teresa; Carreras, Elena; Del Barco, Ester; Del Barco, Ester; Franco-Jarava, Clara; Goya, Maria; Hernandez-Gonzalez, Manuel; Maiz, Nerea; Mendoza, Manel et al.
DOI: 10.1111/aogs.14524